Figure 6.
Aberrant FAM83A contributes to progression of various types of cancer. (a) Analysis of FAM83A CNV in TCGA data sets revealed the FAM83A locus is amplified in 35.5% of pancreatic cancer samples. (b) FAM83A gene CNV and corresponding mRNA expression in a TCGA pancreatic cancer data set (P<0.05, n=177). (c) FAM83A gene CNV and corresponding mRNA expression in a TCGA pancreatic cancer data set (P<0.05, n=177). (d) Kaplan–Meier analysis of overall or disease-free survival for patients with low or high FAM83A expression.